Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 71 trades.
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 36% with bearish.
From the overall spotted trades, 44 are puts, for a total amount of $2,707,496 and 27, calls, for a total amount of $4,083,731.
What's The Price Target?
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $300.0 to $1000.0 for Eli Lilly during the past quarter.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Eli Lilly options trades today is 448.32 with a total volume of 4,764.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Eli Lilly's big money trades within a strike price range of $300.0 to $1000.0 over the last 30 days.
Eli Lilly Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BEARISH | 12/19/25 | $51.9 | $46.9 | $48.0 | $1000.00 | $2.4M | 620 | 1 |
| LLY | PUT | SWEEP | BULLISH | 03/21/25 | $30.2 | $29.85 | $29.85 | $840.00 | $262.6K | 508 | 339 |
| LLY | CALL | TRADE | BEARISH | 03/21/25 | $25.0 | $24.65 | $24.65 | $825.00 | $123.2K | 6 | 55 |
| LLY | PUT | SWEEP | BEARISH | 03/21/25 | $32.1 | $31.55 | $32.1 | $840.00 | $105.9K | 508 | 441 |
| LLY | PUT | SWEEP | BEARISH | 03/14/25 | $76.25 | $74.05 | $75.0 | $895.00 | $97.5K | 687 | 43 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Following our analysis of the options activities associated with Eli Lilly, we pivot to a closer look at the company's own performance.
Where Is Eli Lilly Standing Right Now?
- With a trading volume of 759,402, the price of LLY is down by -0.77%, reaching $823.41.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 51 days from now.
What The Experts Say On Eli Lilly
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $1100.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Wells Fargo has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $1100.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
